CDC Recommends Pfizer Booster at 5 Months, Additional ...

文章推薦指數: 80 %
投票人數:10人

... can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine. Skipdirectlytositecontent Skipdirectlytopageoptions SkipdirectlytoA-Zlink CDCNewsroom SectionNavigation CDCHome Facebook Twitter LinkedIn Syndicate CDCRecommendsPfizerBoosterat5Months,AdditionalPrimaryDoseforCertainImmunocompromisedChildrenEspañol(Spanish) Minus RelatedPages MediaStatementForImmediateRelease:Tuesday,January4,2022 Contact:MediaRelations (404)639-3286 Today,CDCis updating ourrecommendationfor whenmanypeoplecanreceiveaboostershot,shorteningtheintervalfrom6monthsto5monthsforpeoplewhoreceivedthePfizer-BioNTechCOVID-19Vaccine. Thismeansthatpeoplecan nowreceive anmRNAboostershot5months aftercompletingtheirPfizer-BioNTechprimaryseries.  TheboosterintervalrecommendationforpeoplewhoreceivedtheJ&Jvaccine(2months)ortheModernavaccine(6months),hasnotchanged. Additionally,consistentwithourpriorrecommendationforadults,CDCisrecommendingthatmoderatelyorseverelyimmunocompromised5–11-year-oldsreceiveanadditionalprimarydoseofvaccine 28daysaftertheirsecond shot. Atthistime,onlythePfizer-BioNTechCOVID-19vaccineisauthorizedandrecommendedfor children aged 5-11. ThefollowingisattributabletoCDCDirector,Dr.Rochelle Walensky: Aswehavedonethroughoutthepandemic,wewillcontinuetoupdateourrecommendationstoensurethebestpossibleprotectionfortheAmericanpeople.FollowingtheFDA’sauthorizations,today’srecommendationsensurepeopleareabletogetaboostofprotectioninthefaceofOmicronandincreasingcasesacrossthecountry,andensurethatthemostvulnerablechildrencangetanadditionaldosetooptimizeprotectionagainstCOVID-19.Ifyouoryourchildrenareeligibleforathirddoseorabooster,pleasegooutandgetoneassoonasyoucan. Additionally,FDAtookactionthisweektoauthorizeboostersfor12-15yearolds–andIlookforwardtoACIPmeetingonWednesdaytodiscussthisissue. ### U.S.DEPARTMENTOFHEALTHANDHUMANSERVICESexternalicon CDCworks24/7protectingAmerica’shealth,safetyandsecurity.Whetherdiseasestartathomeorabroad,arecurableorpreventable,chronicoracute,orfromhumanactivityordeliberateattack,CDCrespondstoAmerica’smostpressinghealththreats.CDCisheadquarteredinAtlantaandhasexpertslocatedthroughouttheUnitedStatesandtheworld. Pagelastreviewed:January4,2022 Contentsource: CentersforDiseaseControlandPrevention homeNewsroomHome PressMaterialsplusicon CDCNewsroomReleasesplusicon 2022NewsReleases 2021NewsReleases 2020NewsReleases 2019NewsReleases 2018NewsReleases HistoricalNewsReleases JournalSummariesplusicon MMWRSummaries EIDSummaries PCDSummaries DigitalMediaplusicon CDCB-Roll ImageLibrary CDCPressBriefing ContactMediaRelationsplusicon FrequentlyAskedQuestions GetEmailUpdates Toreceiveemailupdatesaboutthispage,enteryouremailaddress: EmailAddress What'sthis? Submit   ConnectwithCDCMedia rss  SubscribetoRSSFeeds govd Subscribetoemail syndication SyndicateonYourSite CDCQuickLinks Data&Statistics FreedomofInformationActOffice PublicHealthImageLibrary(PHIL) Facebook Twitter LinkedIn SAS stats ExitNotification/DisclaimerPolicy Close LinkswiththisiconindicatethatyouareleavingtheCDCwebsite. TheCentersforDiseaseControlandPrevention(CDC)cannotattesttotheaccuracyofanon-federalwebsite. Linkingtoanon-federalwebsitedoesnotconstituteanendorsementbyCDCoranyofitsemployeesofthesponsorsortheinformationandproductspresentedonthewebsite. Youwillbesubjecttothedestinationwebsite'sprivacypolicywhenyoufollowthelink. CDCisnotresponsibleforSection508compliance(accessibility)onotherfederalorprivatewebsite. FormoreinformationonCDC'swebnotificationpolicies,seeWebsiteDisclaimers. Cancel Continue



請為這篇文章評分?